Source: Kalkine Media

Mesoblast: Mesoblast Limited Announces Quotation of New Securities

Highlights Mesoblast Limited quotes new securities on the ASX amounting to 7 255 000 ordinary fully paid shares The new securities are part of an employee incentive scheme Mesoblast operates in the biotechnology sector focusing on cellular medicines f ...

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Silviu Itescu's photo - Managing Director & CEO of Mesoblast

Managing Director & CEO

Silviu Itescu

CEO Approval Rating

90/100

Read more